As a result, our estimate represents the average risk for women with TP53 PVs unselected for family history and would be expected to be lower than the estimates for those with family history of breast cancer—similar to the patterns observed previously for the risks for women with BRCA1/2 PVs.3 The gene discussed is TP53; the disease is breast carcinoma.